Key Takeaways
- Brazil's ANVISA requires complete serialization and aggregation for compliant drug traceability by 2026.
- Track and Trace System Manufacturers in India must ensure real-time event reporting for successful audits.
- 2018-era systems often fail due to incomplete aggregation and lack of electronic reporting capabilities.
- Compliance gaps in validation documentation can lead to serious audit findings under ANVISA's standards.
- Upgrade to a validated track and trace system to protect market access and distributor relationships in Brazil.
Sun Teknovation Pvt Ltd is a Leading Provider of Track & Trace and Machine Vision Solutions for the Global Pharmaceutical Industry.
Brazil is the largest pharmaceutical market in Latin America — and one of the most technically demanding when it comes to drug serialization. ANVISA's National Medicine Control System (SNCM), established under Law No. 13.410 in 2016, has gone through multiple implementation phases, and the expectation bar has risen considerably since the pilot days of 2017–2018.
What Brazil ANVISA SNCM Actually Requires
Brazil’s SNCM provides a complete framework for end-to-end traceability. Every physical movement of a drug from manufacturer to patient must generate an event record submitted electronically to the SNCM. The requirements are specific.
Barcode Standard: Every product must carry a GS1 2D Data Matrix barcode encoding five mandatory data points:
- Global Trade Item Number (GTIN)
- ANVISA Medicine Registry Number (13 digits)
- Unique Serial Number (13 digits)
- Expiry Date (MM/YY format)
- Lot/Batch Number (up to 20 alphanumeric characters)
Aggregation: Unit-level serialization must be linked upward through carton, case, and pallet levels using the IUM (Identificador Único de Medicamentos) for individual packs and the IET (Identificador de Emblem de Transporte) for transport packaging.
Event Reporting: Every stage of the supply chain, including manufacturing, distribution, receipt, and dispensing, must be electronically reported to the SNCM portal by the appropriate stakeholder.
Why 2018-Era Systems Fail Today's Audits
When Brazil's pilot phase ran from 2017 to 2019, many manufacturers set up basic serialization to meet the early pilot scope. Those systems were designed for a world where partial compliance and manual workarounds were acceptable during an experimental phase.
That world no longer applies. Here is where older systems consistently fall short:
- Incomplete aggregation records: The aggregation hierarchy was never fully developed in many early implementations, which serialized at the unit level. ANVISA now requires verifiable linkage from unit to transport package, and missing aggregation data is a direct audit finding.
- No real-time SNCM event reporting — Early systems were often configured for batch export of serialization data. ANVISA's current framework requires event-based reporting tied to actual supply chain movements. A system that generates CSV exports is not the same as one that submits structured event reports to the SNCM portal in real time.
- Validation documentation gaps: According to ANVISA’s GMP standards, systems modified since 2018 without matching revalidation present data integrity concerns, especially with regard to 21 CFR Part 11-equivalent electronic record requirements.
What an Audit-Ready System Looks Like in 2026
A Track and Trace System in India that can genuinely support Brazilian market access today needs to cover these four operational requirements:
- Full unit-level serialization with GS1 Data Matrix encoding all five mandatory ANVISA data points — verified inline at production speed.
- Complete aggregation management — unit to carton to case to pallet, with electronic records linking every level.
- SNCM-compatible event reporting — structured electronic submissions for each supply chain event, not batch file exports
- Validated electronic records — tamper-evident, audit-trail-complete records meeting GMP data integrity expectations.
with these capabilities is not just about passing audits — it is what protects your product's market authorization and your distributor relationships in Brazil from compliance-triggered disruptions.
How Sun Teknovation Addresses This
Sun Teknovation Pvt Ltd.’s track and trace platform — is built for exactly this requirement. As one of the established Track and Trace System Manufacturers in India, our system handles online and offline serialization, full aggregation across all packaging levels, PLC-controlled line automation, and inbuilt electronic reporting — all within a validated, GMP-ready framework.
Key capabilities relevant to Brazil ANVISA compliance:
- Up to 220 cartons per minute — full production speed without compromising verification.
- 21 CFR Part 11 compliant — electronic records and audit trails meeting GMP data integrity standards
- Online and offline track and trace — flexibility for different line configurations without gaps in traceability coverage
- Manual and multi-2D aggregation — complete hierarchy from unit to pallet, verified and recorded electronically.
- Inbuilt reporting server — full traceability data available for regulatory submissions and supply chain event reporting
Why Choose Us
Sun Teknovation Pvt Ltd., has spent 14+ years engineering track and trace and machine vision solutions specifically for regulated pharmaceutical manufacturing. With 1,250+ installations globally and active deployments across ANVISA, DSCSA, EU FMD, BPOM, and other regulated markets, we understand what auditors actually inspect — not just what the regulation document states. Our eTrack platform covers the full compliance stack: serialization, aggregation, electronic event reporting, and validated documentation — everything an Online Track and Trace System in India needs to support demanding export markets like Brazil. When you work with Sun Teknovation Pvt Ltd, your compliance program is built on proven technology with the support to back it up.
Conclusion
Brazil's ANVISA SNCM requirements have moved well past the pilot-phase standards of 2017–2018. Full unit-level serialization, complete aggregation, and electronic SNCM event reporting are now the baseline — not advanced requirements. Systems configured in 2018 that relied on partial serialization, Manual Track and Trace in India, or batch data exports are carrying real compliance risk on every shipment into Brazil. Upgrading to a validated Track and Trace System in India that covers the full ANVISA requirement is the most direct way to protect your Brazilian market access, your product authorizations, and your distributor relationships before an audit surfaces the gaps.Is your track and trace system genuinely ready for Brazil ANVISA audits — or is it running on 2018-era assumptions? Connect with Sun Teknovation Pvt Ltd today to assess your current setup and close the compliance gaps before they become market access problems.
Call us: +91 98982 45695 or Email: connect@sunteknovation.com.
Frequently Asked Questions
Ajay Roshania
Co-Founder & Director (Technical), Sun Teknovation Pvt. Ltd.
Visionary leader driving India’s pharma innovation globally. Expert in turning regulatory challenges into growth opportunities. Leads development of intelligent, future-ready systems that ensure compliance, trust, and scalability. Champion of “Made in India, Trusted Everywhere,” preparing the pharma industry for long-term success.